Posted: 10 December 2024 An Australian research team and their American collaborators have been awarded the 2024 Gordon Bell Prize, regarded as the ‘Nobel Prize’ of high-performance computing (HPC). University of Melbourne Associate Professor Giuseppe Barca and his team were named the winners…
Posted: 10 December 2024 Genomics-driven cancer prevention, testing and treatment strategies will be at the forefront of a new joint venture between the University of Melbourne and Peter MacCallum Cancer Centre (Peter Mac), announced in Melbourne today. The…
Posted: 10 December 2024 People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found. Published in the Journal of the American Heart…
Posted: 10 December 2024 The Southern Hemisphere’s only mRNA manufacturing facility has opened in Victoria – backed by the Albanese and Allan Labor Governments – ensuring world-class mRNA vaccines and medicines can be made in Australia and creating…
Posted: 10 December 2024 The Australian Research Council (ARC) today announced more than $342 million in funding for 536 new projects under the 2025 ARC Discovery Projects scheme. ARC Acting Chief Executive Officer, Dr Richard Johnson, said the…
Posted: 10 December 2024 Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received firm commitments for a placement of 44,444,445 new,…
Posted: 5 December 2024 AGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s…
Posted: 5 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce the successful completion of disease specificity testing for breast cancer. The INOVIQ blood test is a simple, accurate and affordable immunoassay developed using a monoclonal…
Posted: 4 December 2024 Telix and Grand Pharma today announce that a first patient has been dosed in the Phase III ZIRCON-CP trial of TLX250-CDx positron emission tomography (PET) imaging of clear cell renal cell carcinoma (ccRCC). The…
Posted: 4 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that its blood test for ovarian cancer screening has successfully completed an independent patient validation of its biomarkers and diagnostic performance, delivering outstanding test results…
Posted: 4 December 2024 Before her death from cancer in August his year, Dr Depaz was Country Medical Lead and Head of Medical Vaccines for Sanofi Australia & New Zealand, as well as Managing Director of the Translational…
Posted: 4 December 2024 The exceptional research, discovery and advocacy legacy of former WEHI director and Australian treasure Sir Gustav Nossal AC CBE will continue through an ongoing professorship, announced today by WEHI and the Nossal family. Launched with a…